| Advances in understanding the pathophysiology of autism spectrum disorders K Yenkoyan, A Grigoryan, K Fereshetyan, D Yepremyan Behavioural brain research 331, 92-101, 2017 | 154 | 2017 |
| A certain role of SOD/CAT imbalance in pathogenesis of autism spectrum disorders K Yenkoyan, H Harutyunyan, A Harutyunyan Free Radical Biology and Medicine 123, 85-95, 2018 | 73 | 2018 |
| Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder K Fereshetyan, V Chavushyan, M Danielyan, K Yenkoyan Scientific reports 11 (1), 23471, 2021 | 48 | 2021 |
| Modeling neurodegenerative disorders in zebrafish AA Bashirzade, KN Zabegalov, AD Volgin, AS Belova, KA Demin, ... Neuroscience & Biobehavioral Reviews 138, 104679, 2022 | 46 | 2022 |
| Proline-rich polypeptides in Alzheimer's disease and neurodegenerative disorders—Therapeutic potential or a mirage? A Gladkevich, F Bosker, J Korf, K Yenkoyan, H Vahradyan, M Aghajanov Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (7), 1347-1355, 2007 | 44 | 2007 |
| Neuroprotective action of proline-rich polypeptide-1 in β-amyloid induced neurodegeneration in rats K Yenkoyan, K Safaryan, V Chavushyan, I Meliksetyan, G Navasardyan, ... Brain research bulletin 86 (3-4), 262-271, 2011 | 42 | 2011 |
| Intranasal losartan decreases perivascular beta amyloid, inflammation, and the decline of neurogenesis in hypertensive rats HJ Drews, K Yenkoyan, A Lourhmati, M Buadze, D Kabisch, ... Neurotherapeutics 16, 725-740, 2019 | 41 | 2019 |
| Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ... PLoS One 17 (6), e0263595, 2022 | 40 | 2022 |
| Effects of beta-amyloid on behavioral and amino acids spectrum in rats’ brain and their modulation by embryonic proteins K Yenkoyan, K Safaryan, G Navasardyan, L Mkrtchyan, M Aghajanov Neurochemistry international 54 (5-6), 292-298, 2009 | 24 | 2009 |
| The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells G Karapetyan, K Fereshetyan, H Harutyunyan, K Yenkoyan Scientific Reports 12 (1), 17883, 2022 | 23 | 2022 |
| Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients M Movsisyan, A Chopikyan, I Kasparova, G Hakobjanyan, F Carrat, ... Scientific Reports 12 (1), 12403, 2022 | 22 | 2022 |
| Brain-derived neurotrophic factor (BDNF) in perinatal depression: side show or pivotal factor? S Singh, K Fereshetyan, S Shorter, R Paliokha, E Dremencov, ... Drug Discovery Today 28 (2), 103467, 2023 | 21 | 2023 |
| Novel probable glance at inflammatory scenario development in autistic pathology AA Harutyunyan, HA Harutyunyan, KB Yenkoyan Frontiers in Psychiatry 12, 788779, 2021 | 20 | 2021 |
| The role of monoamines in the development of Alzheimer's disease and neuroprotective effect of a proline rich polypeptide K Yenkoyan, K Fereshetyan, S Matinyan, V Chavushyan, M Aghajanov Progress in Neuro-Psychopharmacology and Biological Psychiatry 86, 76-82, 2018 | 20 | 2018 |
| Neuroprotective, neurogenic, and amyloid beta reducing effect of a novel alpha 2-Adrenoblocker, mesedin, on astroglia and neuronal progenitors upon hypoxia and glutamate exposure MM Melkonyan, L Hunanyan, A Lourhmati, N Layer, S Beer-Hammer, ... International Journal of Molecular Sciences 19 (1), 9, 2017 | 17 | 2017 |
| α2-Adrenergic receptor in liver fibrosis: implications for the adrenoblocker mesedin UA Schwinghammer, MM Melkonyan, L Hunanyan, R Tremmel, ... Cells 9 (2), 456, 2020 | 16 | 2020 |
| Current state of modeling human psychiatric disorders using zebrafish FV Costa, TO Kolesnikova, DS Galstyan, NP Ilyin, MS de Abreu, ... International Journal of Molecular Sciences 24 (4), 3187, 2023 | 14 | 2023 |
| Alzheimer's disease-like pathology-triggered oxidative stress, alterations in monoamines levels, and structural damage of locus coeruleus neurons are partially recovered by a … M Aghajanov, V Chavushyan, S Matinyan, M Danielyan, K Yenkoyan Neurochemistry International 131, 104531, 2019 | 14 | 2019 |
| Environmental risk factors in autism spectrum disorder: A narrative review K Yenkoyan, M Mkhitaryan, G Bjørklund Current Medicinal Chemistry 31 (17), 2345-2360, 2024 | 10 | 2024 |
| Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies K Yenkoyan, Z Ounanian, M Mirumyan, L Hayrapetyan, N Zakaryan, ... Current medicinal chemistry 31 (12), 1485, 2024 | 10 | 2024 |
